Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model

Thrombosis Research

Volumn 86, Issue 1, 1997, Pages 49-56

  Gutensohn, K ^a   Beythien, C ^a   Bau, J ^a   Meinertz, T ^a   Kuehnl, P ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Flow cytometry; In vitro; Intracoronary stents; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ANALYTIC METHOD; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; CORONARY ARTERY DISEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STENT; THROMBOCYTE ACTIVATION; THROMBOGENICITY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; ANTIGENS; ANTIGENS, CD; BLOOD PLATELETS; CORONARY VESSELS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; P-SELECTIN; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; STENTS; TANTALUM; THROMBOSIS;

EID: 0031007130     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00044-3     Document Type: Article

References (35)

1. ROUBIN G.S., KING S.B., DOUGLAS J.S., LEMBO N.J., ROBINSON K.A. Intracoronary stenting during percutaneous transluminal angioplasty. Circulation. 81:1990;92-100.
2. GOY J.J., SIGWART U., VOGT P., STAUFFER J.C., KAPPENBERGER L. Long-term clinical and angiographic follow-up of patients treated with the self-expanding intracoronary coronary stent for acute occlusion during balloon angioplasty. J Am Coll Cardiol. 19:1992;1593-1596.
3. BITTL J.A. Advances in coronary angioplasty. N Engl J Med. 335:1996;1290-1302.
4. FISCHMAN D.L., LEON M.B., BAIM D.S., SCHATZ R.A., PENN I., DETRE K., SAVAGE M.P., VELTRI L., RICCI D., NOBUYOSHI M., CLEMAN M., HEUSER R., ALMOND D., TEIRSTEIN P., FISH D., COLOMBO A., BRINKER J., MOSES J., HIRSHFELD J., BAILEY S., ELLIS S., RAKE R., GOLDBERG S. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
5. SERRUYS P.W., DE JAEGERE P., KIEMENEIJ F., MACAYA C., RUTSCH W., HEYNDRICKX G., EMANUELSSON H., MARCO J., LEGRAND V., MATERNE P., BELARDI J., SIGWART U., COLOMBO A., GOY J.J., VAN DEN HUEVEL P., DELCAN J., MOREL M.A. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
6. COLOMBO A., HALL P., NAKAMURA S., ALMAGOR Y., MAIELLO L., MARTINI G., GAGLIONE A., GOLDBERG S.L., TOBIS J.M. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 91:1995;1676-1688.
7. SCHÖMIG A., NEUMANN F.J., KASTRATI A., SCHÜHLEN H., BLASINI R., HADAMITZKY M., WALTER H., ZITZMANN-ROTH E.M., RICHARDT G., ALT E., SCHMITT C., ULM K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089.
8. COURTNEY J.M., LAMBA N.M.K., SUNDARAM S., FORBES C.D. Biomaterials for blood-contacting applications. Biomaterials. 15:1994;737-744.
9. HAYCOX C.L., RATNER B.D. In vitro platelet interactions in whole human blood exposed to biomaterial surfaces: insights in blood compatibility. J Biomed Mater Res. 27:1993;1181-1193.
10. NATH F.C., MULLER D.W., ELLIS S.G., ROSENSCHEIN U., CHAPEKIS A., QUAIN L., ZIMMERMAN C., TOPOL E.J. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Am Coll Cardiol. 21:1993;622-627.
11. SHATTIL J.S., CUNNINGHAM M., HOXIE J.A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies. Blood. 70:1987;307-315.
12. SCHARF R.E., TOMER A., MARZEC U.M., TEIRSTEIN P.S., RUGGERI Z.M., HARKER L.A. Activation of platelets in blood perfusing angioplasty damaged coronary arteries. Arteriosclerosis. 12:1992;1475-1487.
13. TSCHOEPE D., SCHULTHEIß H.P., KOLAROV P., SCHWIPPERT B., DANNEHL K., NIEUWENHUIS H.K., KEHREL B., STRAUER B., GRIES F.A. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation. 88:1993;37-42.
14. GAWAZ M., NEUMANN F.J., OTT I., MAY A., SCHÖMIG A. Platelet activation and coronary stent implantation. Circulation. 94:1996;279-285.
15. NACHMAN R.L., SILVERSTEIN R. Hypercoagulable states. Ann Intern Med. 119:1993;819-827.
16. AULT K.A., MITCHELL J. Analysis of platelets by flow cytometry. Methods Cell Biol. 42:1994;275-294.
17. BEYTHIEN C., TERRES W., HAMM C.W. In vitro model to test the thrombogenicity of coronary stents. Thromb Res. 75:1994;581-590.
18. RUF A., PATSCHEKE H. Flow cytometric detection of activated platelets: comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost. 21:1995;146-151.
19. McEVER R.P., MARTIN M.N. A monoclonal antibody to a membrane glycoprotein binds only on activated platelets. J Biol Chem. 259:1984;9799-9804.
20. NIEUWENHUIS H.K., VAN OOSTERHOUT J.J.G., ROZEMULLER E., VAN IWAARDEN F., SIXMA J.J. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood. 70:1987;838-845.
21. HELLUMS, J.D., and HARDWICK, R.A.: Response of platelets to shear stress: a review. In: The Rheology of Blood, Blood Vessels and Associated Tissues, eds. Gross, D.R., Hwang, N.H.C.: Sijthoff en Noordhoff, Div. Martinus Nijhoff, Alphen aan den Rijn, The Netherlands, 1981, p. 160-183.
22. CLEMETSON, K.J.: Glycoproteins of the platelet plasma membrane. In: Platelet Membrane Glycoproteins, eds. George, J.N., Nurden, A.T., Phillips, D.R.: Plenum, New York, 1985, p. 51-85.
23. DU X., BEUTLER L., RUAN C., CASTALDI P.A., BERNDT M.C. Glycoprotein Ib and glycoprotein IX are fully complexed in the intact platelet membrane. Blood. 69:1987;1524-1527.
24. PEERSCHKE E.I.B. Platelet membrane glycoproteins. AJCP. 98:1992;455-463.
25. JENNINGS L.K., PHILIPPS D.R. Purification of glycoproteins IIb and III from human platelet membranes and characterization of a calcium-dependent glycoprotein IIb-IIIa complex. J Biol Chem. 257:1982;10458-10463.
26. RINDER C.S., MATHEW J.P., RINDER H.M., BONAN J., AULT K.A., SMITH B.R. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology. 75:1991;563-570.
27. MUSIAL J., NIEWIAROWSKI S., HERSHOCK D., MORINELLI T.A., COLMAN R.W., EDMUNDS L.H. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med. 105:1985;514-522.
28. GEORGE J.N., PICKET E.B., SAUCERMAN S., McEVER R.P., KUNICKI T.J., KIEFER N., NEWMAN P.J. Platelet surface glycoproteins: studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 78:1986;340-348.
29. GINSBERG M.H., LOFTUS J.C., PLOW E.F. Cytoadhesins, integrins, and platelets. Thromb Haemost. 59:1988;1-6.
30. BELVAL T.K., HELLUMS J.D., SOLIS R.T. The kinetics of platelet aggregation induced by fluid-shearing stress. Microvasc Res. 28:1984;279-284.
31. INOUE T., SAKAI Y., FUJITO T., HOSHI K., HAYASHI T., TAKAYANAGI K., MOROOKA S., SOHMA R. Expression of activation-dependent platelet membrane protein after coronary stenting: a comparison with balloon angioplasty. Circulation. 94:1996;1518.
32. ITOH, T., NAKAI, K., ONO, M., and HIRAMORI, K. Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selection? Coron Artery Dis, 645-650, 1995.
33. DEL MASCHIO A., DEJANA E., BAZZONI G. Bidirectional modulation of platelet and polymorphnuclear leukocyte activities. Ann Hematol. 67:1993;23-31.
34. HAMBURGER S.A., McEVER R.P. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 75:1990;550-554.
35. RINDER C.S., BONAN J.L., RINDER H.M., MATHEW J., HINES R., SMITH B.R. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 79:1992;1201-1205.